Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic …
R Admiraal, S Nierkens, MA de Witte… - The Lancet …, 2017 - thelancet.com
Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
[引用][C] Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective …
R Admiraal, S Nierkens, MA de Witte… - The Lancet …, 2017 - cir.nii.ac.jp
Association between anti-thymocyte globulin exposure and survival outcomes in adult
unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis …
unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis …
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic …
R Admiraal, S Nierkens, MA de Witte… - The Lancet …, 2017 - infona.pl
Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after
allogeneic haemopoietic cell transplantation (HCT). However, ATG can also cause delayed …
allogeneic haemopoietic cell transplantation (HCT). However, ATG can also cause delayed …
[引用][C] Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective …
R Admiraal, S Nierkens… - Lancet …, 2017 - scholarlypublications …
Association between anti-thymocyte globulin exposure and survival outcomes in adult
unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort …
unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort …
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic …
R Admiraal, S Nierkens, MA de Witte, EJ Petersen… - The Lancet …, 2017 - Elsevier
Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
[PDF][PDF] Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective …
R Admiraal, S Nierkens, MA de Witte, EJ Petersen… - 2017 - academia.edu
Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective …
R Admiraal, S Nierkens, MA de Witte… - The Lancet …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective …
R Admiraal, S Nierkens, MA de Witte… - The Lancet …, 2017 - europepmc.org
Background Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …
(GvHD) after allogeneic haemopoietic cell transplantation (HCT). However, ATG can also …